Johnson & Johnson
A healthcare maker of prescription medicines — treatments for cancer, immune and nerve conditions, including DARZALEX and STELARA — plus medical devices such as ACUVUE contact lenses and surgical tools. Three Johnson brothers founded it in 1886 in New Jersey, inspired by a lecture on antiseptic surgery. Fun fact: an employee created BAND-AID bandages in 1920 for his wife, who kept cutting herself while cooking.
Granted 1.20M · Sold 315.8K
Granted 1.94M · Sold 264.5K
Granted 1.89M · Sold 1.50M
Granted 1.10M · Sold 637.7K
Granted 125.0K · Sold 125.0K
Granted 481.3K · Sold 192.8K
Granted 573.5K · Sold 312.2K
Granted 285.9K · Sold 56.7K
Granted 611.0K · Sold 539.2K
Granted 297.4K · Sold 97.0K
Granted 857.7K · Sold 608.8K
Granted 270.0K · Sold 134.3K
Granted 174.0K · Sold 132.9K
Granted 202.7K · Sold 146.2K
Granted 27.9K · Sold 26.0K
Granted 72.6K · Sold 45.7K
Granted 162.4K · Sold 160.0K
Granted 178.1K
Granted 51.1K · Sold 25.2K
Granted 208.6K · Sold 172.7K
Granted 136.8K · Sold 109.0K
Granted 17.1K
Granted 27.6K · Sold 13.8K
Granted 193.9K · Sold 102.3K
Granted 101.4K · Sold 63.1K
Granted 15.2K
Granted 101.6K · Sold 59.4K
Granted 153.7K · Sold 94.8K
Granted 21.7K · Sold 17.9K
Granted 9.6K · Bought 17.9K
Granted 68.2K · Sold 52.1K
Granted 37.6K
Granted 59.2K
Granted 59.4K · Sold 24.3K
Granted 136.2K · Sold 123.1K
Granted 48.7K
Granted 43.8K · Sold 15.1K
Granted 14.1K
Granted 55.1K · Sold 50.7K
Granted 9.1K · Bought 15.5K
Granted 19.0K · Sold 7.6K
Granted 17.7K
Granted 11.4K
Granted 5.4K
Granted 19.0K · Sold 7.6K
Granted 17.4K · Sold 7.0K
Granted 4.9K
Granted 5.8K · Bought 748
Granted 102.7K · Sold 96.7K
Bought 5.0K
Granted 4.2K
Granted 2.5K
Bought 3.0K
Bought 1.3K
Granted 44.6K · Sold 112.1K
Bought 1.0K
Bought 100
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Duato JoaquinCEO and Chairman of the Board, Director · 78 transactions | — | 911.2K | 1.20M | — | 315.8K |
| Gorsky AlexDirector · 68 transactions | — | 768.3Kas of Jan 2023 | 1.94M | — | 264.5K |
| Weldon William CFormer Chairman of the Board · 82 transactions | — | 409.1Kas of Feb 2013 | 1.89M | — | 1.50M |
| Stoffels PaulusVice Chair, Exec Committee · 55 transactions | — | 289.9Kas of Feb 2021 | 1.10M | — | 637.7K |
| Darretta Robert JVice Chairman, Director · 18 transactions | — | 209.1Kas of Feb 2007 | 125.0K | — | 125.0K |
| Taubert Jennifer LEVP, WWC. Innovative Medicine · 54 transactions | — | 194.5K | 481.3K | — | 192.8K |
| Caruso Dominic JExec VP, Finance, CFO · 81 transactions | — | 172.0Kas of Feb 2018 | 573.5K | — | 312.2K |
| Heisen Joann HeffernanVP, Chief Information Officer · 1 transaction | — | 169.3Kas of Jan 2006 | — | — | — |
| Ullmann Michael HExec VP, General Counsel · 65 transactions | — | 166.8Kas of Feb 2022 | 285.9K | — | 56.7K |
| Deyo Russell CVP, General Counsel · 106 transactions | — | 166.7Kas of Feb 2012 | 611.0K | — | 539.2K |
| Wengel Kathryn EEVP, Chief TO and Risk Officer · 66 transactions | — | 124.7K | 297.4K | — | 97.0K |
| Fasolo PeterExec VP, Chief HR Officer · 352 transactions | — | 112.5Kas of Feb 2024 | 857.7K | — | 608.8K |
| Wolk Joseph JExec VP, CFO · 66 transactions | — | 110.0K | 270.0K | — | 134.3K |
| Goggins Colleen AMember, Executive Committee · 54 transactions | — | 109.0Kas of Jan 2011 | 174.0K | — | 132.9K |
| Cosgrove Stephen JCorporate Controller · 90 transactions | — | 105.6Kas of Jan 2015 | 202.7K | — | 146.2K |
| Pruden Gary JExec VP, WW Chair, Med Devices · 7 transactions | — | 97.2Kas of Mar 2017 | 27.9K | — | 26.0K |
| McCoy Sherilyn SMember, Executive Committee · 24 transactions | — | 84.9Kas of Feb 2012 | 72.6K | — | 45.7K |
| Dormer Michael JMember, Executive Committee · 13 transactions | — | 84.0Kas of Oct 2006 | 162.4K | — | 160.0K |
| Peterson Sandra EExec VP, Group WW Chairman · 21 transactions | — | 83.3Kas of Feb 2018 | 178.1K | — | — |
| Valeriani Nicholas JVP, Strategy & Growth, Director · 46 transactions | — | 81.3Kas of Oct 2009 | 51.1K | — | 25.2K |
| Sneed Michael EEVP, Global Corp Aff & CCO · 21 transactions | — | 67.7Kas of Feb 2021 | 208.6K | — | 172.7K |
| Mongon ThibautExec VP, WW Chair, Cons Health · 63 transactions | — | 65.9Kas of Feb 2023 | 136.8K | — | 109.0K |
| Poon Christine AVice Chairman, Director · 15 transactions | — | 62.3Kas of Feb 2009 | 17.1K | — | — |
| Casey Donald M Jr.Member, Executive Committee · 6 transactions | — | 58.8Kas of Sep 2009 | 27.6K | — | 13.8K |
| McEvoy AshleyEVP, WW Chair, MedTech · 29 transactions | — | 55.1Kas of Aug 2023 | 193.9K | — | 102.3K |
| Swanson James D.EVP, CIO · 36 transactions | — | 46.2K | 101.4K | — | 63.1K |
| Mammen MathaiEVP, Pharm, R&D · 4 transactions | — | 41.9Kas of Feb 2022 | 15.2K | — | — |
| Hait WilliamSee Remarks · 30 transactions | — | 39.1Kas of Feb 2024 | 101.6K | — | 59.4K |
| Reed John CEVP, Innovative Medicine, R&D · 20 transactions | — | 35.9K | 153.7K | — | 94.8K |
| Peterson Per AExecutive Committee Member · 10 transactions | — | 32.8Kas of Feb 2007 | 21.7K | — | 17.9K |
| Prince CharlesDirector · 13 transactions | — | 29.3Kas of Dec 2018 | 9.6K | 17.9K | — |
| Decker Robert JVP Corporate Controller · 55 transactions | — | 28.5K | 68.2K | — | 52.1K |
| Mullin Leo FDirector · 17 transactions | — | 27.4Kas of Feb 2014 | 37.6K | — | — |
| Mesquita Jorge S.Exec VP, WW Chair, Consumer · 7 transactions | — | 27.3Kas of Feb 2019 | 59.2K | — | — |
| Schmid TimothyEVP, WW Chair, MedTech · 30 transactions | — | 26.2K | 59.4K | — | 24.3K |
| Scodari Joseph CRetired Exec Committee Member · 28 transactions | — | 25.6Kas of May 2008 | 136.2K | — | 123.1K |
| Forminard ElizabethEVP, Chief Legal Officer · 31 transactions | — | 23.5K | 48.7K | — | — |
| Broadhurst VanessaEVP, Global Corp Affairs · 35 transactions | — | 23.0K | 43.8K | — | 15.1K |
| Mulholland KristenEVP, Chief HR Officer · 18 transactions | — | 19.7K | 14.1K | — | — |
| Kapusta Ronald AController, CAO · 33 transactions | — | 19.0Kas of Feb 2019 | 55.1K | — | 50.7K |
| Perez William DDirector · 24 transactions | — | 16.0Kas of Mar 2020 | 9.1K | 15.5K | — |
| Lindquist Susan LDirector · 9 transactions | — | 16.0Kas of Feb 2015 | 19.0K | — | 7.6K |
| Satcher DavidDirector · 12 transactions | — | 15.4Kas of Feb 2013 | 17.7K | — | — |
| Johns Michael M EDirector · 7 transactions | — | 15.3Kas of Feb 2014 | 11.4K | — | — |
| Jordan Ann DibbleDirector · 3 transactions | — | 13.3Kas of Mar 2007 | 5.4K | — | — |
| Coleman Mary SueDirector · 12 transactions | — | 12.0Kas of Nov 2015 | 19.0K | — | 7.6K |
| Langbo Arnold GDirector · 15 transactions | — | 10.2Kas of Mar 2010 | 17.4K | — | 7.0K |
| Reinemund StevenDirector · 3 transactions | — | 7.6Kas of Mar 2008 | 4.9K | — | — |
| Mulcahy Anne MDirector · 7 transactions | — | 6.5Kas of Dec 2018 | 5.8K | 748 | — |
| Foster-Cheek Kaye IVP, Human Resources · 28 transactions | — | 5.8Kas of Jan 2010 | 102.7K | — | 96.7K |
| Joly HubertDirector · 1 transaction | — | 5.0Kas of Dec 2019 | — | 5.0K | — |
| Davis IanDirector · 3 transactions | — | 4.2Kas of Feb 2014 | 4.2K | — | — |
| Williams Ronald ADirector · 2 transactions | — | 3.6Kas of Jun 2014 | 2.5K | — | — |
| Hewson Marillyn ADirector · 1 transaction | — | 3.0Kas of Jun 2019 | — | 3.0K | — |
| Morikis John GDirector · 1 transaction | — | 1.8K | — | 1.3K | — |
| Cullen JamesDirector · 29 transactions | — | 1.5Kas of Sep 2014 | 44.6K | — | 112.1K |
| Weinberger Mark ADirector · 1 transaction | — | 1.0Kas of Dec 2024 | — | 1.0K | — |
| Johnson Paula ADirector · 1 transaction | — | 191as of Aug 2023 | — | — | — |
| Woods Eugene A.Director · 1 transaction | — | 150as of Feb 2025 | — | 100 | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -6.41M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.